Philippines vs Sao Tome and Principe: Hepatitis B surface antigen (HBsAg) prevalence
Philippines
0.8%
in 2024
Sao Tome and Principe
0.8%
in 2024
Philippines rank
39th
Sao Tome and Principe rank
39th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Philippines
- Sao Tome and Principe
How they compare
Philippines currently reports 0.8% against 0.8% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2015 it was Sao Tome and Principe ahead.
Philippines ranks 39th and Sao Tome and Principe ranks 39th of 194 countries.
Across the 2 decades both report, Philippines averaged higher in 1 and Sao Tome and Principe in 1.
Head to head by decade
| Decade | Philippines | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 0.9% | 0.0% | Sao Tome and Principe |
| 2020s | 0.9% | 0.8% | 0.1% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Philippines or Sao Tome and Principe?
- Philippines, at 0.8% against 0.8% in Sao Tome and Principe as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Philippines and Sao Tome and Principe?
- 0.0%, with Philippines ahead.
- How many years of comparable data are there for Philippines and Sao Tome and Principe?
- 10 years are reported by both, from 2015 to 2024.
- How do Philippines and Sao Tome and Principe rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Philippines ranks 39th and Sao Tome and Principe ranks 39th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.